Using Recombinant DNA

Uses

Recombinant DNA has a variety of applications. These applications can be hugely beneficial in combating a number of humanitarian issues. These include:

Genetically modified crops

Recombinant DNA can be used to genetically modify crops to improve their yield.
Traits that can be improved include -
- Resistance to disease.
- Tolerance to the application of herbicides and pesticides.
- Tolerance of adverse environmental conditions (e.g. drought).

Genetically modified livestock

Recombinant DNA can be used by farmers to make the production of meat more economically viable.
Traits that can be improved include -
- Grow faster and larger.
- Resistance to disease.

Increased nutritional value

Recombinant DNA can be used to increase the nutritional value of food.
- E.g. Rice has been genetically modified to contain Vitamin A. Vitamin A is a common deficiency in Asian countries where rice is widely consumed.

Treating diseases

Recombinant DNA can be used to produce medicine and hormones to treat diseases.
- E.g. Individuals with type I diabetes used to be given pig insulin to control their blood sugar levels. Now human insulin is created using genetically modified bacteria.

Industry

Recombinant DNA can be used to manufacture enzymes.
These enzymes can be used in industry.
- E.g. Rennet is an enzyme traditionally taken from the stomach of young mammals like calves to produce cheese. It is now possible to make rennet using genetically engineered bacteria.

Ethical Concerns

Although recombinant DNA technology can be hugely beneficial, there are concerns raised by environmentalists and anti-globalisation activists in opposition to the use of recombinant DNA technology.

Spread of genes

Genetically modified (GM) crops and livestock are produced when a beneficial gene is inserted into their genome to improve a certain trait.
The genes could be transferred into other organisms where it is harmful.
- E.g. A gene for herbicide resistance could be passed on to a weed, or a gene for antibiotic resistance to pathogenic bacteria.
Genes from genetically engineered (transgenic) crops could also spread to organic crops.

Unforeseen impacts

Genetic modifications to an organism could have unforeseen effects and disrupt normal gene function.
The use of genetically engineered organisms could lead to a reduction in the variety in populations.
- If variety in a population decreases, biodiversity also decreases.
- Low biodiversity can have negative impacts (e.g. extinction is more likely).

Economic consequences

There could be economic consequences for some countries if genetically engineered crops can be grown in different countries where previously it was not possible.
Companies who are able to invest more money in recombinant DNA technology may out-compete others.

Medical uses

Some activists are concerned that using recombinant DNA in medicine could lead to unethical uses of genetic engineering.
- E.g. Selecting specific traits in offspring (designer babies).

Gene Therapy

Gene therapy is a genetic engineering technique used to cure disease.

Procedure

Gene therapy involves the introduction of a target gene (the gene that confers a beneficial trait) into the genome.
- The genome has been transformed.
The target gene is then transcribed and translated to produce the desired protein.
The protein counteracts the effect of a disease that is caused by a mutation.

Allele interactions

Gene therapy is used to treat diseases that are caused by a mutation in a gene.
The way that gene therapy is used depends on the allele interactions of the gene that causes the disease.
- If the mutation is in the recessive allele, a wild-type (typical of the species) dominant allele is inserted into the genome. The dominant allele counteracts the mutant alleles.
- If the mutation is in the dominant allele, an allele that 'silences' the mutant allele is inserted in the genome.

Vectors

Gene therapy uses vectors to insert the target gene into the genome.
Vectors transport allow the gene to be taken up by the cells of the host. The genome is then transformed.
- Types of vector include plasmids and bacteriophages.

Types of gene therapy

There are two types of gene therapy -
- Somatic therapy - altering of alleles in adult body cells.
- Germline therapy - altering of alleles in sex cells. This is illegal in humans.

1Biological Molecules

1.1Monomers & Polymers

1.1.1Monomers & Polymers

1.1.2Condensation & Hydrolysis Reactions

1.2Carbohydrates

1.2.1Structure of Carbohydrates

1.2.2Types of Polysaccharides

1.2.3End of Topic Test - Monomers, Polymers and Carbs

1.2.4Exam-Style Question - Carbohydrates

1.2.5A-A* (AO3/4) - Carbohydrates

1.3Lipids

1.3.1Triglycerides & Phospholipids

1.3.2Types of Fatty Acids

1.3.3Testing for Lipids

1.3.4Exam-Style Question - Fats

1.3.5A-A* (AO3/4) - Lipids

1.4Proteins

1.4.1The Peptide Chain

1.4.2Investigating Proteins

1.4.3Primary & Secondary Protein Structure

1.4.4Tertiary & Quaternary Protein Structure

1.4.5Enzymes

1.4.6Factors Affecting Enzyme Activity

1.4.7Enzyme-Controlled Reactions

1.4.8End of Topic Test - Lipids & Proteins

1.4.9A-A* (AO3/4) - Enzymes

1.4.10A-A* (AO3/4) - Proteins

1.5Nucleic Acids

1.5.1DNA & RNA

1.5.2Polynucleotides

1.5.3DNA Replication

1.5.4Exam-Style Question - Nucleic Acids

1.5.5A-A* (AO3/4) - Nucleic Acids

1.6ATP

1.6.1Structure of ATP

1.6.2End of Topic Test - Nucleic Acids & ATP

1.7Water

1.7.1Structure & Function of Water

1.7.2A-A* (AO3/4) - Water

1.8Inorganic Ions

1.8.1Inorganic Ions

1.8.2End of Topic Test - Water & Inorganic Ions

2Cells

2.1Cell Structure

2.1.1Introduction to Cells

2.1.2Eukaryotic Cells & Organelles

2.1.3Eukaryotic Cells & Organelles 2

2.1.4Prokaryotes

2.1.5A-A* (AO3/4) - Organelles

2.1.6Methods of Studying Cells

2.1.7Microscopes

2.1.8End of Topic Test - Cell Structure

2.1.9Exam-Style Question - Cells

2.1.10A-A* (AO3/4) - Cells

2.2Mitosis & Cancer

2.2.1Mitosis

2.2.2Investigating Mitosis

2.2.3Cancer

2.2.4A-A* (AO3/4) - The Cell Cycle

2.3Transport Across Cell Membrane

2.3.1Cell Membrane Structure

2.3.2A-A* (AO3/4) - Membrane Structure

2.3.3Diffusion

2.3.4Osmosis

2.3.5Active Transport

2.3.6End of Topic Test - Mitosis, Cancer & Transport

2.3.7Exam-Style Question - Membranes

2.3.8A-A* (AO3/4) - Membranes & Transport

2.3.9A-A*- Mitosis, Cancer & Transport

2.4Cell Recognition & the Immune System

2.4.1Immune System

2.4.2The Immune Response

2.4.3Antibodies

2.4.4Primary & Secondary Response

2.4.5Vaccines

2.4.6HIV

2.4.7Ethical Issues

2.4.8End of Topic Test - Immune System

2.4.9Exam-Style Question - Immune System

2.4.10A-A* (AO3/4) - Immune System

3Substance Exchange

3.1Surface Area to Volume Ratio

3.1.1Size & Surface Area

3.1.2A-A* (AO3/4) - Cell Size

3.2Gas Exchange

3.2.1Single-Celled Organisms

3.2.2Multicellular Organisms

3.2.3Control of Water Loss

3.2.4Human Gas Exchange

3.2.5Ventilation

3.2.6Dissection

3.2.7Measuring Gas Exchange

3.2.8Lung Disease

3.2.9Lung Disease Data

3.2.10End of Topic Test - Gas Exchange

3.2.11A-A* (AO3/4) - Gas Exchange

3.3Digestion & Absorption

3.3.1Overview of Digestion

3.3.2Digestion in Mammals

3.3.3Absorption

3.3.4End of Topic Test - Substance Exchange & Digestion

3.3.5A-A* (AO3/4) - Substance Ex & Digestion

3.4Mass Transport

3.4.1Haemoglobin

3.4.2Oxygen Transport

3.4.3The Circulatory System

3.4.4The Heart

3.4.5Blood Vessels

3.4.6Cardiovascular Disease

3.4.7Heart Dissection

3.4.8Xylem

3.4.9Phloem

3.4.10Investigating Plant Transport

3.4.11End of Topic Test - Mass Transport

3.4.12A-A* (AO3/4) - Mass Transport

4Genetic Information & Variation

4.1DNA, Genes & Chromosomes

4.1.1DNA

4.1.2Genes

4.1.3A-A* (AO3/4) - DNA

4.2DNA & Protein Synthesis

4.2.1Protein Synthesis

4.2.2Transcription & Translation

4.2.3End of Topic Test - DNA, Genes & Protein Synthesis

4.2.4Exam-Style Question - Protein Synthesis

4.2.5A-A* (AO3/4) - Coronavirus Translation

4.2.6A-A* (AO3/4) - Transcription

4.2.7A-A* (AO3/4) - Translation

4.3Mutations & Meiosis

4.3.1Mutations

4.3.2Meiosis

4.3.3A-A* (AO3/4) - Meiosis

4.3.4Meiosis vs Mitosis

4.3.5End of Topic Test - Mutations, Meiosis

4.3.6A-A* (AO3/4) - DNA,Genes, CellDiv & ProtSynth

4.4Genetic Diversity & Adaptation

4.4.1Genetic Diversity

4.4.2Natural Selection

4.4.3A-A* (AO3/4) - Natural Selection

4.4.4Adaptations

4.4.5Investigating Natural Selection

4.4.6End of Topic Test - Genetic Diversity & Adaptation

4.4.7A-A* (AO3/4) - Genetic Diversity & Adaptation

4.5Species & Taxonomy

4.5.1Classification

4.5.2DNA Technology

4.5.3A-A* (AO3/4) - Species & Taxonomy

4.6Biodiversity Within a Community

4.6.1Biodiversity

4.6.2Agriculture

4.6.3End of Topic Test - Species,Taxonomy& Biodiversity

4.6.4A-A* (AO3/4) - Species,Taxon&Biodiversity

4.7Investigating Diversity

4.7.1Genetic Diversity

4.7.2Quantitative Investigation

5Energy Transfers (A2 only)

6Responding to Change (A2 only)

6.1Nervous Communication

6.1.1Survival

6.1.2Plant Responses

6.1.3Animal Responses

6.1.4Reflexes

6.1.5End of Topic Test - Reflexes, Responses & Survival

6.1.6Receptors

6.1.7The Human Retina

6.1.8Control of Heart Rate

6.1.9End of Topic Test - Receptors, Retina & Heart Rate

6.2Nervous Coordination

6.2.1Neurones

6.2.2Action Potentials

6.2.3Speed of Transmission

6.2.4End of Topic Test - Neurones & Action Potentials

6.2.5Synapses

6.2.6Types of Synapse

6.2.7Medical Application

6.2.8End of Topic Test - Synapses

6.2.9A-A* (AO3/4) - Nervous Comm&Coord

6.3Muscle Contraction

6.3.1Skeletal Muscle

6.3.2Sliding Filament Theory

6.3.3Contraction

6.3.4Slow & Fast Twitch Fibres

6.3.5End of Topic Test - Muscles

6.3.6A-A* (AO3/4) - Muscle Contraction

6.4Homeostasis

6.4.1Overview of Homeostasis

6.4.2Blood Glucose Concentration

6.4.3Controlling Blood Glucose Concentration

6.4.4End of Topic Test - Blood Glucose

6.4.5Primary & Secondary Messengers

6.4.6Diabetes Mellitus

6.4.7Measuring Glucose Concentration

6.4.8Osmoregulation

6.4.9Controlling Blood Water Potential

6.4.10ADH

6.4.11End of Topic Test - Diabetes & Osmoregulation

6.4.12A-A* (AO3/4) - Homeostasis

7Genetics & Ecosystems (A2 only)

7.1Genetics

7.1.1Key Terms in Genetics

7.1.2Inheritance

7.1.3Linkage

7.1.4Multiple Alleles & Epistasis

7.1.5Chi-Squared Test

7.1.6End of Topic Test - Genetics

7.1.7A-A* (AO3/4) - Genetics

7.2Populations

7.2.1Populations

7.2.2Hardy-Weinberg Principle

7.3Evolution

7.3.1Variation

7.3.2Natural Selection & Evolution

7.3.3End of Topic Test - Populations & Evolution

7.3.4Types of Selection

7.3.5Types of Selection Summary

7.3.6Overview of Speciation

7.3.7Causes of Speciation

7.3.8Diversity

7.3.9End of Topic Test - Selection & Speciation

7.3.10A-A* (AO3/4) - Populations & Evolution

7.4Populations in Ecosystems

7.4.1Overview of Ecosystems

7.4.2Niche

7.4.3Population Size

7.4.4Investigating Population Size

7.4.5End of Topic Test - Ecosystems & Population Size

7.4.6Succession

7.4.7Conservation

7.4.8End of Topic Test - Succession & Conservation

7.4.9A-A* (AO3/4) - Ecosystems

8The Control of Gene Expression (A2 only)

8.1Mutation

8.1.1Mutations

8.1.2Effects of Mutations

8.1.3Causes of Mutations

8.2Gene Expression

8.2.1Stem Cells

8.2.2Stem Cells in Disease

8.2.3End of Topic Test - Mutation & Gene Epression

8.2.4A-A* (AO3/4) - Mutation & Stem Cells

8.2.5Regulating Transcription

8.2.6Epigenetics

8.2.7Epigenetics & Disease

8.2.8Regulating Translation

8.2.9Experimental Data

8.2.10End of Topic Test - Transcription & Translation

8.2.11Tumours

8.2.12Correlations & Causes

8.2.13Prevention & Treatment

8.2.14End of Topic Test - Cancer

8.2.15A-A* (AO3/4) - Gene Expression & Cancer

8.3Genome Projects

8.3.1Using Genome Projects

8.4Gene Technology

8.4.1Recombinant DNA

8.4.2Producing Fragments

8.4.3Amplification

8.4.4End of Topic Test - Genome Project & Amplification

8.4.5Using Recombinant DNA

8.4.6Medical Diagnosis

8.4.7Genetic Fingerprinting

8.4.8End of Topic Test - Gene Technologies

8.4.9A-A* (AO3/4) - Gene Technology

Jump to other topics